Jennifer Inra

Statistics

Publications

Citations

688

H-Index

Active since

2002

Affiliations

Harvard University(Current)

Massachusetts General Hospital

Biogen (United States)

Emory University

Sheffield Teaching Hospitals NHS Foundation Trust

Jennifer Inra is an author at Harvard University specializing in neurodegenerative disorders, clinical pharmacology, and neurodegenerative disease pharmacotherapy.

Publications per year

2002–2026

Publications

Trial of Cinpanemab in Early Parkinson’s Disease

Anthony E. Lang, Andrew Siderowf, Eric A. Macklin et al. · New England Journal of Medicine · 2022 · 333 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

High expression of the Met receptor in prostate cancer metastasis to bone

Beatrice S. Knudsen, Glenn A. Gmyrek, Jennifer Inra et al. · Urology · 2002 · 184 citations

Medicine, Cancer Biology, Oncology +16

Safety, tolerability, and pharmacokinetics of antisense oligonucleotide BIIB078 in adults with C9orf72-associated amyotrophic lateral sclerosis: a phase 1, randomised, double blinded, placebo-controlled, multiple ascending dose study

Leonard H. van den Berg, Jeffrey D. Rothstein, Pamela J. Shaw et al. · The Lancet Neurology · 2024 · 70 citations · Full text

Life Sciences, Neurology, Pharmacokinetics +12

An active learning curriculum improves fellows&rsquo; knowledge and faculty teaching skills

Jennifer Inra, Stephen R. Pelletier, Navin L. Kumar et al. · Advances in Medical Education and Practice · 2017 · 25 citations · Full text

Education, Curriculum, Medical Education +9

Serious Neurologic Adverse Events in Tofersen Clinical Trials for Amyotrophic Lateral Sclerosis

Alexandra Lovett, Sowmya Chary, Suma Babu et al. · Muscle & Nerve · 2025 · 25 citations · Full text

Life Sciences, Neurology, Neuroscience +13

1–5 of 8